Rapid optimization and prototyping for therapeutic antibody-like molecules
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rapid optimization and prototyping for therapeutic antibody-like molecules
Authors
Keywords
-
Journal
mAbs
Volume 5, Issue 2, Pages 237-254
Publisher
Informa UK Limited
Online
2013-03-26
DOI
10.4161/mabs.23363
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Directed evolution of stabilized IgG1-Fc scaffolds by application of strong heat shock to libraries displayed on yeast
- (2012) Michael W. Traxlmayr et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3
- (2012) C. F. McDonagh et al. MOLECULAR CANCER THERAPEUTICS
- Affinity Maturation to Improve Human Monoclonal Antibody Neutralization Potency and Breadth against Hepatitis C Virus
- (2011) Yong Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Rational engineering of antibody therapeutics targeting multiple oncogene pathways
- (2011) Jonathan Fitzgerald et al. mAbs
- Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synthetic single-framework antibody library integrated with rapid affinity maturation by VL shuffling
- (2011) E.- C. Brockmann et al. PROTEIN ENGINEERING DESIGN & SELECTION
- High-throughput measurement, correlation analysis, and machine-learning predictions for pH and thermal stabilities of Pfizer-generated antibodies
- (2011) Amy C. King et al. PROTEIN SCIENCE
- Heterotrimerization of the Growth Factor Receptors erbB2, erbB3, and Insulin-like Growth Factor-I Receptor in Breast Cancer Cells Resistant to Herceptin
- (2010) X. Huang et al. CANCER RESEARCH
- Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM×anti-CD3) as a targeted cancer immunotherapy
- (2010) Diane Seimetz et al. CANCER TREATMENT REVIEWS
- Targeting Multiple Kinase Pathways: A Change In Paradigm
- (2010) L. Gossage et al. CLINICAL CANCER RESEARCH
- New Strategies in Head and Neck Cancer: Understanding Resistance to Epidermal Growth Factor Receptor Inhibitors
- (2010) L. F. Chen et al. CLINICAL CANCER RESEARCH
- Combination mTOR and IGF-1R Inhibition: Phase I Trial of Everolimus and Figitumumab in Patients with Advanced Sarcomas and Other Solid Tumors
- (2010) R. Quek et al. CLINICAL CANCER RESEARCH
- Stable IgG-like Bispecific Antibodies Directed toward the Type I Insulin-like Growth Factor Receptor Demonstrate Enhanced Ligand Blockade and Anti-tumor Activity
- (2010) Jianying Dong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti-tumor activity of stability-engineered IgG-like bispecific antibodies targeting TRAIL-R2 and LTβR
- (2010) Jennifer S. Michaelson et al. mAbs
- Enhanced antibody half-life improves in vivo activity
- (2010) Jonathan Zalevsky et al. NATURE BIOTECHNOLOGY
- An improved yeast transformation method for the generation of very large human antibody libraries
- (2010) Lorenzo Benatuil et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Stability engineering of scFvs for the development of bispecific and multivalent antibodies
- (2010) Brian R. Miller et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Automated minimization of steric clashes in protein structures
- (2010) Srinivas Ramachandran et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Insulin-Like Growth Factor-1 Receptor Inhibition Induces a Resistance Mechanism via the Epidermal Growth Factor Receptor/HER3/AKT Signaling Pathway: Rational Basis for Cotargeting Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor in Hepatocellular Carcinoma
- (2009) C. Desbois-Mouthon et al. CLINICAL CANCER RESEARCH
- High-Throughput Thermal Scanning: A General, Rapid Dye-Binding Thermal Shift Screen for Protein Engineering
- (2009) Jason J. Lavinder et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Engineering of stable bispecific antibodies targeting IL-17A and IL-23
- (2009) Robert Mabry et al. PROTEIN ENGINEERING DESIGN & SELECTION
- Structural understanding of stabilization patterns in engineered bispecific Ig-like antibody molecules
- (2009) Jacob L. Jordan et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor-PI3K Axis
- (2009) B. Schoeberl et al. Science Signaling
- A Decade of Yeast Surface Display Technology: Where Are We Now?
- (2008) Eric Shusta et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- SCWRL and MolIDE: computer programs for side-chain conformation prediction and homology modeling
- (2008) Qiang Wang et al. Nature Protocols
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation